MedPath

Comparision of two drugs named Phenylephrine and Norepinephrine to decrease the occurance of low blood pressure after spinal anaesthesia in cesarean deliveries.

Phase 1
Not yet recruiting
Conditions
Sequelae of complication of pregnancy, childbirth, and the puerperium,
Registration Number
CTRI/2020/09/027704
Lead Sponsor
Pramukh Swami Medical College and Shree Krishna Hospital and Research Center
Brief Summary

Hypotension is a very common consequence of the sympathetic vasomotor block caused by spinal anaesthesia for cesarean section. Severe hypotension in obstetrics patient will lead to decreased oragn perfusion, dyspnoea, nausea, vomiting in the mother and depressed APGAR score and fetal acidosis in the fetus. The measures in the form of positioning to prevent aortocaval compression and pre or co loading of crystelloids have not been proven to completely prevent post spinal hypotension. Vasopressors like ephedrine and phenylephrine are being used routinely nowadays to prevent or treat post spinal hypotension in addition to above mentioned measures. Both vasopressors have their own pros and cons and various studies have been done to check their efficacy and safety profile. Phenylephrine is the preffered agent as per the literatures available. Norepinephrine has been found to have better profile as a vasopressor theoritically. There are on;y few studies to support this. So we planned to do comparative study of effects of npth drugs by intravenous infusion on feto-metarnal outcomes ny preventing and treating post spinal hypotension in cesarean sections.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
70
Inclusion Criteria

All pregnant patients undergoing elective and emergency cesarian who have been given consent for American Society of Anesthesiologists grade 2 and 3 and do not have contraindication to any of the drugs to be studied.

Exclusion Criteria

1)Pregnant females with gestational age of less than 36 weeks 2)Known co-morbidities such as severe pregnancy induced hypertension, Diabetes Mellitus, cardiac diseases, epilepsy, eclampsia 3)Patient refusing for spinal anaesthesia 4)contraindication for spinal anaesthesia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Systolic blood pressuredifferent hemodynaemic and vital parameters at different point of time after spinal anaesthesia | 1)baseline | 2)at 2 minutes | 3)at 4 minutes | 4)at 6 minutes | 5)at 8 minutes | 6)at 10 minutes | 7)at 15 minutes | 8)at 20 minutes | 10)at 30 minutes | 11)at 45 minutes | 12)at 60 minutes
3)Mean arterial pressuredifferent hemodynaemic and vital parameters at different point of time after spinal anaesthesia | 1)baseline | 2)at 2 minutes | 3)at 4 minutes | 4)at 6 minutes | 5)at 8 minutes | 6)at 10 minutes | 7)at 15 minutes | 8)at 20 minutes | 10)at 30 minutes | 11)at 45 minutes | 12)at 60 minutes
4)Heart ratedifferent hemodynaemic and vital parameters at different point of time after spinal anaesthesia | 1)baseline | 2)at 2 minutes | 3)at 4 minutes | 4)at 6 minutes | 5)at 8 minutes | 6)at 10 minutes | 7)at 15 minutes | 8)at 20 minutes | 10)at 30 minutes | 11)at 45 minutes | 12)at 60 minutes
2)Diastolic blood pressuredifferent hemodynaemic and vital parameters at different point of time after spinal anaesthesia | 1)baseline | 2)at 2 minutes | 3)at 4 minutes | 4)at 6 minutes | 5)at 8 minutes | 6)at 10 minutes | 7)at 15 minutes | 8)at 20 minutes | 10)at 30 minutes | 11)at 45 minutes | 12)at 60 minutes
Secondary Outcome Measures
NameTimeMethod
occurance of materal nausea and vomitingat any given time
APGAR scoreat 1 minute and 5 minutes

Trial Locations

Locations (1)

Shree Krishna Hospital and Research Center

🇮🇳

Anand, GUJARAT, India

Shree Krishna Hospital and Research Center
🇮🇳Anand, GUJARAT, India
Dr Madhavi Chaudhari
Principal investigator
9427084963
madhavic@charutarhealth.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.